Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma
Clinical trial NCT00868608 · COMPLETED
Trial details
- NCT number
- NCT00868608
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-30
- Primary completion
- 2012-01-10
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.